Primary human hepatocytes on biodegradable poly(l-lactic acid) matrices: A promising model for improving transplantation efficiency with tissue engineering

Liver Transplantation

Volumn 17, Issue 2, 2011, Pages 104-114

  Török, Eva ^a   Lutgehetmann, Marc ^a   Bierwolf, Jeanette ^a   Melbeck, Stefan ^a   Düllmann, Jochen ^a   Nashan, Bjoern ^a   Ma, Peter X ^b   Pollok, Joerg M ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA 1 ANTITRYPSIN; POLY(LEVO LACTIC ACID); POLYMER; TISSUE SCAFFOLD; UNCLASSIFIED DRUG; UREA;

ARTICLE; BIODEGRADABILITY; CELL CULTURE; CELL STRUCTURE; CELL SURVIVAL; COATED PIT; CYTOSKELETON; HEPATOCYTE TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER FUNCTION; MICROVILLUS; PRIORITY JOURNAL; SURFACE PROPERTY; TISSUE ENGINEERING;

ABSORBABLE IMPLANTS; ALPHA 1-ANTITRYPSIN; BIOLOGICAL MARKERS; BIOREACTORS; BLOTTING, NORTHERN; CELL SEPARATION; CELL SHAPE; CELL SURVIVAL; CELLS, CULTURED; FLUORESCENT ANTIBODY TECHNIQUE; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; LACTIC ACID; LIVER REGENERATION; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; POLYMERS; SERUM ALBUMIN; TIME FACTORS; TISSUE ENGINEERING; TISSUE SCAFFOLDS; UREA;

EID: 79551504497     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22200     Document Type: Article

References (56)

1. Gupta S, Aragona E, Vemuru RP, Bhargava KK, Burk RD, Chowdhury JR,. Permanent engraftment and function of hepatocytes delivered to the liver: implications for gene therapy and liver repopulation. HEPATOLOGY 1991; 14: 144-149.
2. Gupta S, Chowdhary JR,. Hepatocyte transplantation: back to the future. HEPATOLOGY 1992; 15: 156-162.
3. Strom SC, Fisher RA, Rubinstein WS, Barranger JA, Towbin RB, Charron M, et al. Transplantation of human hepatocytes. Transplant Proc 1997; 29: 2103-2106.
4. Kobayashi N, Ito M, Nakamura J, Cai J, Gao C, Hammel JM, Fox IJ,. Hepatocyte transplantation in rats with decompensated cirrhosis. HEPATOLOGY 2000; 31: 851-857.
5. Kobayashi N, Ito M, Nakamura J, Cai J, Hammel JM, Fox IJ,. Treatment of carbon tetrachloride and phenobarbital-induced chronic liver failure with intrasplenic hepatocyte transplantation. Cell Transplant 2000; 9: 671-673.
6. Kobayashi N, Miyazaki M, Fukaya K, Inoue Y, Sakaguchi M, Noguchi H, et al. Treatment of surgically induced acute liver failure with transplantation of highly differentiated immortalized human hepatocytes. Cell Transplant 2000; 9: 733-735. (Pubitemid 32002585)
7. Fisher RA, Bu D, Thompson M, Wolfe L, Ritter JK,. Optimization of conditions for clinical human hepatocyte infusion. Cell Transplant 2004; 13: 677-689.
8. Hughes RD, Mitry RR, Dhawan A, Lehec SC, Girlanda R, Rela M, et al. Isolation of hepatocytes from livers from non-heart-beating donors for cell transplantation. Liver Transpl 2006; 12: 713-717.
9. Vacanti JP, Morse MA, Saltzman WM, Domb AJ, Perez-Atayde A, Langer R,. Selective cell transplantation using bioabsorbable artificial polymers as matrices. J Pediatr Surg 1988; 23(1 Pt 2): 3-9.
10. Kim SS, Utsunomiya H, Koski JA, Wu BM, Cima MJ, Sohn J, et al. Survival and function of hepatocytes on a novel three-dimensional synthetic biodegradable polymer scaffold with an intrinsic network of channels. Ann Surg 1998; 228: 8-13.
11. Fox IJ, Chowdhury JR, Kaufman SS, Goertzen TC, Chowdhury NR, Warkentin PI, et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 1998; 338: 1422-1426.
12. Sokal EM, Sokol R, Cormier V, Lacaille F, McKiernan P, Van Spronsen FJ, et al. Liver transplantation in mitochondrial respiratory chain disorders. Eur J Pediatr 1999; 158 (suppl 2): S81-S84.
13. Fitzpatrick E, Mitry RR, Dhawan A,. Human hepatocyte transplantation: state of the art. J Intern Med 2009; 266: 339-357.
14. Muraca M, Gerunda G, Neri D, Vilei MT, Granato A, Feltracco P, et al. Hepatocyte transplantation as a treatment for glycogen storage disease type 1a. Lancet 2002; 359: 317-318.
15. Sokal EM, Smets F, Bourgois A, Van Maldergem L, Buts JP, Reding R, et al. Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up. Transplantation 2003; 76: 735-738.
16. Horslen SP, Fox IJ,. Hepatocyte transplantation. Transplantation 2004; 77: 1481-1486.
17. Strom SC, Fisher RA, Thompson MT, Sanyal AJ, Cole PE, Ham JM, Posner MP,. Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation 1997; 63: 559-569.
18. Chowdhury JR, Grossman M, Gupta S, Chowdhury NR, Baker JR Jr, Wilson JM,. Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits. Science 1991; 254: 1802-1805.
19. Grossman M, Rader DJ, Muller DW, Kolansky DM, Kozarsky K, Clark BJ III, et al. A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nat Med 1995; 1: 1148-1154.
20. Raper SE, Grossman M, Rader DJ, Thoene JG, Clark BJ III, Kolansky DM, et al. Safety and feasibility of liver-directed ex vivo gene therapy for homozygous familial hypercholesterolemia. Ann Surg 1996; 223: 116-126.
21. Kay MA, Baley P, Rothenberg S, Leland F, Fleming L, Ponder KP, et al. Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes. Proc Natl Acad Sci U S A 1992; 89: 89-93.
22. Sano K, Cusick RA, Lee H, Pollok JM, Kaufmann PM, Uyama S, et al. Regenerative signals for heterotopic hepatocyte transplantation. Transplant Proc 1996; 28: 1857-1858.
23. Cusick RA, Lee H, Sano K, Pollok JM, Utsunomiya H, Ma PX, et al. The effect of donor and recipient age on engraftment of tissue-engineered liver. J Pediatr Surg 1997; 32: 357-360.
24. Kneser U, Kaufmann PM, Fiegel HC, Pollok JM, Kluth D, Herbst H, Rogiers X,. Long-term differentiated function of heterotopically transplanted hepatocytes on three-dimensional polymer matrices. J Biomed Mater Res 1999; 47: 494-503.
25. Pollok JM, Kluth D, Cusick RA, Lee H, Utsunomiya H, Ma PX, et al. Formation of spheroidal aggregates of hepatocytes on biodegradable polymers under continuous-flow bioreactor conditions. Eur J Pediatr Surg 1998; 8: 195-199.
26. Torok E, Pollok JM, Ma PX, Vogel C, Dandri M, Petersen J, et al. Hepatic tissue engineering on 3-dimensional biodegradable polymers within a pulsatile flow bioreactor. Dig Surg 2001; 18: 196-203.
27. Torok E, Pollok JM, Ma PX, Kaufmann PM, Dandri M, Petersen J, et al. Optimization of hepatocyte spheroid formation for hepatic tissue engineering on three-dimensional biodegradable polymer within a flow bioreactor prior to implantation. Cells Tissues Organs 2001; 169: 34-41.
28. Torok E, Vogel C, Lutgehetmann M, Ma PX, Dandri M, Petersen J, et al. Morphological and functional analysis of rat hepatocyte spheroids generated on poly(l-lactic acid) polymer in a pulsatile flow bioreactor. Tissue Eng 2006; 12: 1881-1890.
29. Ma PX, Langer R,. Morphology and mechanical function of long-term in vitro engineered cartilage. J Biomed Mater Res 1999; 44: 217-221.
30. Blaheta RA, Kronenberger B, Woitaschek D, Schick C, Oppermann E, Auth MK, et al. Interference of soluble mediators into liver matrix triggered dedifferentiation of human hepatocytes. Transplant Proc 1999; 31: 502-504.
31. Schroder AJ, Blaheta RA, Scholz M, Kronenberger B, Encke A, Markus BH,. Effects of proinflammatory cytokines on cultivated primary human hepatocytes. Fluorometric measurement of intercellular adhesion molecule-1 and human leukocyte antigen-A, -B, -C, and -DR expression. Transplantation 1995; 59: 1023-1028.
32. Dandri M, Burda MR, Torok E, Pollok JM, Iwanska A, Sommer G, et al. Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. HEPATOLOGY 2001; 33: 981-988. (Pubitemid 32246649)
33. Asonuma K, Gilbert JC, Stein JE, Takeda T, Vacanti JP,. Quantitation of transplanted hepatic mass necessary to cure the Gunn rat model of hyperbilirubinemia. J Pediatr Surg 1992; 27: 298-301.
34. Asonuma K, Vacanti JP,. Cell transplantation as replacement therapy for the future. Crit Care Nurs Clin North Am 1992; 4: 249-254.
35. Enosawa S, Miyashita T, Suzuki S, Li XK, Tsunoda M, Amemiya H, et al. Long-term culture of glutamine synthetase-transfected HepG2 cells in circulatory flow bioreactor for development of a bioartificial liver. Cell Transplant 2000; 9: 711-715.
36. Fukuda J, Okamura K, Nakazawa K, Ijima H, Yamashita Y, Shimada M, et al. Efficacy of a polyurethane foam/spheroid artificial liver by using human hepatoblastoma cell line (Hep G2). Cell Transplant 2003; 12: 51-58.
37. Starzl TE, Demetris AJ, Van Thiel D,. Liver transplantation (1). N Engl J Med 1989; 321: 1014-1022.
38. Ambrosino G, Varotto S, Basso SM, Cecchetto A, Carraro P, Naso A, et al. Hepatocyte transplantation in the treatment of acute liver failure: microencapsulated hepatocytes versus hepatocytes attached to an autologous biomatrix. Cell Transplant 2003; 12: 43-49.
39. Pollok JM, Vacanti JP,. Tissue engineering. Semin Pediatr Surg 1996; 5: 191-196.
40. Gregory PG, Connolly CK, Gillis BE, Sullivan SJ,. The effect of coculture with nonparenchymal cells on porcine hepatocyte function. Cell Transplant 2001; 10: 731-738.
41. Mitry RR, Hughes RD, Dhawan A,. Progress in human hepatocytes: isolation, culture & cryopreservation. Semin Cell Dev Biol 2002; 13: 463-467.
42. Mooney D, Hansen L, Vacanti J, Langer R, Farmer S, Ingber D,. Switching from differentiation to growth in hepatocytes: control by extracellular matrix. J Cell Physiol 1992; 151: 497-505.
43. Hansen LK, Mooney DJ, Vacanti JP, Ingber DE,. Integrin binding and cell spreading on extracellular matrix act at different points in the cell cycle to promote hepatocyte growth. Mol Biol Cell 1994; 5: 967-975.
44. Kaufmann PM, Fiegel HC, Kneser U, Pollok JM, Kluth D, Rogiers X,. Influence of pancreatic islets on growth and differentiation of hepatocytes in co-culture. Tissue Eng 1999; 5: 583-596.
45. Block GD, Locker J, Bowen WC, Petersen BE, Katyal S, Strom SC, et al. Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF alpha in a chemically defined (HGM) medium. J Cell Biol 1996; 132: 1133-1149.
46. Alexandre E, Viollon-Abadie C, David P, Gandillet A, Coassolo P, Heyd B, et al. Cryopreservation of adult human hepatocytes obtained from resected liver biopsies. Cryobiology 2002; 44: 103-113.
47. Li AP,. Human hepatocytes: isolation, cryopreservation and applications in drug development. Chem Biol Interact 2007; 168: 16-29.
48. Ostrowska A, Bode DC, Pruss J, Bilir B, Smith GD, Zeisloft S,. Investigation of functional and morphological integrity of freshly isolated and cryopreserved human hepatocytes. Cell Tissue Bank 2000; 1: 55-68.
49. Mitry RR, Dhawan A, Hughes RD, Bansal S, Lehec S, Terry C, et al. One liver, three recipients: segment IV from split-liver procedures as a source of hepatocytes for cell transplantation. Transplantation 2004; 77: 1614-1616.
50. Chong TW, Smith RL, Hughes MG, Camden J, Rudy CK, Evans HL, et al. Primary human hepatocytes in spheroid formation to study hepatitis C infection. J Surg Res 2006; 130: 52-57.
51. Elkayam T, Amitay-Shaprut S, Dvir-Ginzberg M, Harel T, Cohen S,. Enhancing the drug metabolism activities of C3A - a human hepatocyte cell line - by tissue engineering within alginate scaffolds. Tissue Eng 2006; 12: 1357-1368.
52. Li J, Li L, Yu H, Cao H, Gao C, Gong Y,. Growth and metabolism of human hepatocytes on biomodified collagen poly(lactic-co-glycolic acid) three-dimensional scaffold. ASAIO J 2006; 52: 321-327.
53. 2 gas-foaming method as a scaffold for three-dimensional growth of Hep3B cells. Biotechnol Bioeng 2008; 100: 998-1009.
54. Risbud MV, Karamuk E, Schlosser V, Mayer J,. Hydrogel-coated textile scaffolds as candidate in liver tissue engineering: II. Evaluation of spheroid formation and viability of hepatocytes. J Biomater Sci Polym Ed 2003; 14: 719-731.
55. Martini WZ, Wolf SE, Chinkes DL, Chung KK, Dubick MA, Blackbourne L, Yu YM,. Enhanced albumin synthesis in severely burned adults. Shock 2010; 34: 364-368.
56. Sohlenius-Sternbeck AK,. Determination of the hepatocellularity number for human, dog, rabbit, rat and mouse livers from protein concentration measurements. Toxicol In Vitro 2006; 20: 1582-1586.